Panelists explain that KMT2A-rearranged acute myeloid leukemia (AML) is an aggressive, molecularly distinct leukemia subtype marked by menin-dependent transcriptional dysregulation, poor response ...

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that largely affects older adults. Discover the causes, risk factors, how it’s classified, and more information like on ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Panelists report that the AUGMENT-101 trial demonstrated meaningful clinical benefits of menin inhibitors in ...

Acute myeloid leukemia, or AML, is a type of cancer that affects the bone marrow and blood. Learn about outlook and survival rates for this cancer.

Due to their pseudonymous nature, cryptocurrencies can be used for illicit activities. Compliance with KYC and AML regulations is the standout way to mitigate these risks. Adhere to Regulatory ...

The European Commission has approved Astellas’ Xospata (gilteritinib) for patients with relapsed or refractory FLT3-positive acute myeloid leukemia (AML), cementing its lead over a rival drug ...

Cell-surface targeted therapies have emerged as a highly effective class of therapeutics for both solid tumours and haematologic malignancies. However, acute myeloid leukaemia (AML) has remained ...

Targeted Oncology TM: How does ICT01’s T-cell activation differ from other AML immunotherapies? Maiti: So far, we have always known that AML is a tumor that is susceptible to immune surveillance and ...

See the most recent Aston Martin (LSE:AML) share price, news, company analysis, and price history from our financial experts.